Results 271 to 280 of about 382,913 (294)
Some of the next articles are maybe not open access.
Reperfused Myocardium: Stunning, Preconditioning, and Reperfusion Injury
1990In the late 1960s, when the deathtoll from myocardial infarction had caused a high level of public awareness, the National Institutes of Health, USA, decided to fund projects directly related to the experimental treatment of infarcts, to develop animal models best suited to study infarct size after coronary occlusion, and to develop quantitative ...
Wolfgang Schaper +2 more
openaire +1 more source
1989
Thrombolysis with intravenous streptokinase, APSAC and tissue plasminogen activator has been shown to improve ventricular function and survival in patients with acute myocardial infarction (1–4). Despite these important advances several problems remain and we may not have achieved the optimal benefit from reperfusion therapy.
B. Pitt, B. Lucchesi
openaire +1 more source
Thrombolysis with intravenous streptokinase, APSAC and tissue plasminogen activator has been shown to improve ventricular function and survival in patients with acute myocardial infarction (1–4). Despite these important advances several problems remain and we may not have achieved the optimal benefit from reperfusion therapy.
B. Pitt, B. Lucchesi
openaire +1 more source
Myocardial reperfusion and reperfusion injury: current views.
Bratislavske lekarske listy, 1991Salvage of the ischaemic/infarcting myocardium has been the goal of both experimental and clinical cardiologists for many years. Of the various approaches, including the array of pharmacological methods that have been tried to date, the restoration of myocardial blood flow must now be accepted as the undisputed means of achieving this goal.
openaire +1 more source
Therapeutic Coronary Reperfusion and Reperfusion Injury: An Introduction
Cardiology, 2016Jeffrey S, Borer, Basil S, Lewis
openaire +3 more sources
Presse medicale (Paris, France : 1983), 2001
IMPORTANCE OF ISCHEMIA-REPERFUSION LESIONS: After transplantation, ischemia-reperfusion lesions are associated with an increased risk of acute rejection, late recovery of liver function, or chronic graft dysfunction. In all, about 20% of the grafts are lost. The importance of prevention is evident. HEME-OXYGENASE: It has been shown that heme-oxygenase,
openaire +1 more source
IMPORTANCE OF ISCHEMIA-REPERFUSION LESIONS: After transplantation, ischemia-reperfusion lesions are associated with an increased risk of acute rejection, late recovery of liver function, or chronic graft dysfunction. In all, about 20% of the grafts are lost. The importance of prevention is evident. HEME-OXYGENASE: It has been shown that heme-oxygenase,
openaire +1 more source